Review



fas inhibitor c75  (Cayman Chemical)


Bioz Verified Symbol Cayman Chemical is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cayman Chemical fas inhibitor c75
    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of <t>FAS,</t> <t>SCD1,</t> and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    Fas Inhibitor C75, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/c75+fasn+inhibitor/pmc09292025-33-0-13
    Average 90 stars, based on 1 article reviews
    fas inhibitor c75 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids"

    Article Title: Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids

    Journal: Stem Cells

    doi: 10.1002/stem.3452

    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of FAS, SCD1, and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    Figure Legend Snippet: Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of FAS, SCD1, and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Techniques Used: Derivative Assay, Comparison, Western Blot

    Increased expression of the lipogenic enzymes in human breast cancer tissues. A,C,E, Representative image of IHC analysis for SCD1 (A), FAS (C), and FADS1 (E) expressions in normal and tumor tissues. ANT, tumor‐adjacent normal tissue; T, tumor. B,D,F, Representative image of immunohistochemistry (IHC) analysis for SCD1 (B), FAS (D), and FADS1 (F) expressions between various clinical and tumor grades (G1‐3). *** P < .001 vs vehicle‐treated control cells. Alphabet letters were used to show the significant difference between groups. Each subfigure contains representative image (top) and quantitative results (bottom). The quantitative results were plotted by the values of minimum to maximum
    Figure Legend Snippet: Increased expression of the lipogenic enzymes in human breast cancer tissues. A,C,E, Representative image of IHC analysis for SCD1 (A), FAS (C), and FADS1 (E) expressions in normal and tumor tissues. ANT, tumor‐adjacent normal tissue; T, tumor. B,D,F, Representative image of immunohistochemistry (IHC) analysis for SCD1 (B), FAS (D), and FADS1 (F) expressions between various clinical and tumor grades (G1‐3). *** P < .001 vs vehicle‐treated control cells. Alphabet letters were used to show the significant difference between groups. Each subfigure contains representative image (top) and quantitative results (bottom). The quantitative results were plotted by the values of minimum to maximum

    Techniques Used: Expressing, Immunohistochemistry, Control

    n‐3 PUFA inhibit tumor growth of breast cancer stem cells in xenograft mouse model. A, Representative image of tumor‐bearing mice. Prior to implanting 1.5 × 10 7 of MCF‐7‐CSC to nude mice, these mice were orally gavaged by either fish oil (n‐3 PUFA) or corn oil (control) for a month and continued giving oils until the end of the experiment. B, Tumor growth of the nude mice in each group. C, Relative tumor weight by body weight. D, The ratio of n‐6/n‐3 PUFA. E, The ratio of MUFA (C16:1 + C18:1)/SFA (C16:0 + C18:0). F, The ratio of C20:4/C18:2. G,H, Protein levels (G) and mRNA levels (H) of SCD1, FAS, FADS2, and COX2 between control and n‐3 PUFA groups. n = 3 to 4. * P < .05; ** P < .01; *** P < .001 vs control. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    Figure Legend Snippet: n‐3 PUFA inhibit tumor growth of breast cancer stem cells in xenograft mouse model. A, Representative image of tumor‐bearing mice. Prior to implanting 1.5 × 10 7 of MCF‐7‐CSC to nude mice, these mice were orally gavaged by either fish oil (n‐3 PUFA) or corn oil (control) for a month and continued giving oils until the end of the experiment. B, Tumor growth of the nude mice in each group. C, Relative tumor weight by body weight. D, The ratio of n‐6/n‐3 PUFA. E, The ratio of MUFA (C16:1 + C18:1)/SFA (C16:0 + C18:0). F, The ratio of C20:4/C18:2. G,H, Protein levels (G) and mRNA levels (H) of SCD1, FAS, FADS2, and COX2 between control and n‐3 PUFA groups. n = 3 to 4. * P < .05; ** P < .01; *** P < .001 vs control. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Techniques Used: Control

    Related Articles

    Control:

    Article Title: Metabolic control of the scaffold protein TKS5 in tissue-invasive, pro-inflammatory T cells
    Article Snippet: .. For experiments targeting anabolic lipogenesis, chimeric mice carrying the same synovial tissue were randomly assigned to three treatment arms: (A) control (vehicle); (B) treatment with FAS inhibitor C75 (5 mg/kg/mouse qad, # 191282-48-1 Cayman Chemical); or ML265 (10 mg/kg/mouse qd, #1221186-53-3 Cayman Chemical). ..



    Similar Products

    96
    MedChemExpress acid fa synthesis inhibitor c75
    Acid Fa Synthesis Inhibitor C75, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/C75/10__1097_slash_cad__0000000000001713-70-11-16
    Average 96 stars, based on 1 article reviews
    acid fa synthesis inhibitor c75 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Danaher Inc fatty acid synthase fas inhibitor c75
    Disrupting Wolbachia -induced lipid droplets facilitates viral replication in w Mel- Aag2 cell line. Wolbachia -free and w Mel- Aag2 cell lines were mock-infected or DENV-2 infected at MOI 1 for 24 h. Prior to DENV-2 infection cells were pre-treated with <t>C75</t> for 24 h, and C75 was maintained during the time of infection. ( A–B ) Cell-associated RNA and virus supernatant were collected from each cell line 24 h post-DENV-2-infection for analysis by qRT-PCR ( A ) and TCID 50 ( B ). Data are the median number of viral genome copies ± IQR relative to the RPS17 mosquito housekeeping gene ( A ) or the median TCID 50 /mL ± IQR ( B ). The numbers in parentheses represent the average number of Wolbachia per cell ( Wolbachia 16S rRNA/RPS17 ), determined in parallel wells for each independent experiment prior to DENV-2 inoculation. Data are representative of at least three ( A ) or two independent experiments ( B ) with triplicate biological replicates each. Statistical analyses were performed using Mann-Whitney test, where ** P < 0.001 and **** P < 0.0001. ( C ) Wolbachia -free (top panel) and w Mel- Aag2 cell lines (bottom panel) were stained with BODIPY (green) and DAPI (blue). Wolbachia was detected with an α-WSP antibody (red) and 4G2 hybridoma fluid against flavivirus group E antigen for DENV-2 staining (magenta). Slides were imaged as 3-dimensional z-stacks and 2D images generated by MIP using Fiji software. Scale bars = 15 µm. ( D ) LD numbers were quantified 24 h post-DENV-2 infection at MOI 1. LD numbers were analyzed using Fiji software. Data are the mean LD number ± SEM from at least 6 fields of view representing at least 80 cells in total, where each data point represents the mean LD number from a single field of view. Statistical analyses were performed by an unpaired two-tailed student’s t -test, where **** P < 0.0001. ( E ) TEM of Wolbachia -free and w Mel- Aag2 cell lines mock-infected or DENV-2 infected at MOI 1 for 24 h and treated with C75 as previously described. Scale bar = 500 nm. ER, endoplasmic reticulum; W, Wolbachia ; M, mitochondria; Vp, vesicle packets.
    Fatty Acid Synthase Fas Inhibitor C75, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/pmc10865983-252-9-15
    Average 86 stars, based on 1 article reviews
    fatty acid synthase fas inhibitor c75 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Schmid GmbH inhibitor of fas c75
    Disrupting Wolbachia -induced lipid droplets facilitates viral replication in w Mel- Aag2 cell line. Wolbachia -free and w Mel- Aag2 cell lines were mock-infected or DENV-2 infected at MOI 1 for 24 h. Prior to DENV-2 infection cells were pre-treated with <t>C75</t> for 24 h, and C75 was maintained during the time of infection. ( A–B ) Cell-associated RNA and virus supernatant were collected from each cell line 24 h post-DENV-2-infection for analysis by qRT-PCR ( A ) and TCID 50 ( B ). Data are the median number of viral genome copies ± IQR relative to the RPS17 mosquito housekeeping gene ( A ) or the median TCID 50 /mL ± IQR ( B ). The numbers in parentheses represent the average number of Wolbachia per cell ( Wolbachia 16S rRNA/RPS17 ), determined in parallel wells for each independent experiment prior to DENV-2 inoculation. Data are representative of at least three ( A ) or two independent experiments ( B ) with triplicate biological replicates each. Statistical analyses were performed using Mann-Whitney test, where ** P < 0.001 and **** P < 0.0001. ( C ) Wolbachia -free (top panel) and w Mel- Aag2 cell lines (bottom panel) were stained with BODIPY (green) and DAPI (blue). Wolbachia was detected with an α-WSP antibody (red) and 4G2 hybridoma fluid against flavivirus group E antigen for DENV-2 staining (magenta). Slides were imaged as 3-dimensional z-stacks and 2D images generated by MIP using Fiji software. Scale bars = 15 µm. ( D ) LD numbers were quantified 24 h post-DENV-2 infection at MOI 1. LD numbers were analyzed using Fiji software. Data are the mean LD number ± SEM from at least 6 fields of view representing at least 80 cells in total, where each data point represents the mean LD number from a single field of view. Statistical analyses were performed by an unpaired two-tailed student’s t -test, where **** P < 0.0001. ( E ) TEM of Wolbachia -free and w Mel- Aag2 cell lines mock-infected or DENV-2 infected at MOI 1 for 24 h and treated with C75 as previously described. Scale bar = 500 nm. ER, endoplasmic reticulum; W, Wolbachia ; M, mitochondria; Vp, vesicle packets.
    Inhibitor Of Fas C75, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/inhibitor+of+fas+c75/pm35240536-106-5-6
    Average 90 stars, based on 1 article reviews
    inhibitor of fas c75 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical fas inhibitor c75
    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of <t>FAS,</t> <t>SCD1,</t> and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    Fas Inhibitor C75, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/c75+fasn+inhibitor/pmc09292025-33-0-13
    Average 90 stars, based on 1 article reviews
    fas inhibitor c75 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical fatty acid synthase (fas) inhibitor c75
    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of <t>FAS,</t> <t>SCD1,</t> and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    Fatty Acid Synthase (Fas) Inhibitor C75, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/c75+fasn+inhibitor/pm25351207-188-12-21
    Average 90 stars, based on 1 article reviews
    fatty acid synthase (fas) inhibitor c75 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly c75, a fatty acid synthase (fas) inhibitor
    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of <t>FAS,</t> <t>SCD1,</t> and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    C75, A Fatty Acid Synthase (Fas) Inhibitor, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/c75++a+fatty+acid+synthase++fas++inhibitor/pm17710465-7087-11-4
    Average 90 stars, based on 1 article reviews
    c75, a fatty acid synthase (fas) inhibitor - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    FASgen Inc c75, a slow-binding inhibitor of mammalian fas
    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of <t>FAS,</t> <t>SCD1,</t> and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
    C75, A Slow Binding Inhibitor Of Mammalian Fas, supplied by FASgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+inhibitor+c75/c75++a+slow+binding+inhibitor+of+mammalian+fas/pm17404812-45-6-10
    Average 90 stars, based on 1 article reviews
    c75, a slow-binding inhibitor of mammalian fas - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Disrupting Wolbachia -induced lipid droplets facilitates viral replication in w Mel- Aag2 cell line. Wolbachia -free and w Mel- Aag2 cell lines were mock-infected or DENV-2 infected at MOI 1 for 24 h. Prior to DENV-2 infection cells were pre-treated with C75 for 24 h, and C75 was maintained during the time of infection. ( A–B ) Cell-associated RNA and virus supernatant were collected from each cell line 24 h post-DENV-2-infection for analysis by qRT-PCR ( A ) and TCID 50 ( B ). Data are the median number of viral genome copies ± IQR relative to the RPS17 mosquito housekeeping gene ( A ) or the median TCID 50 /mL ± IQR ( B ). The numbers in parentheses represent the average number of Wolbachia per cell ( Wolbachia 16S rRNA/RPS17 ), determined in parallel wells for each independent experiment prior to DENV-2 inoculation. Data are representative of at least three ( A ) or two independent experiments ( B ) with triplicate biological replicates each. Statistical analyses were performed using Mann-Whitney test, where ** P < 0.001 and **** P < 0.0001. ( C ) Wolbachia -free (top panel) and w Mel- Aag2 cell lines (bottom panel) were stained with BODIPY (green) and DAPI (blue). Wolbachia was detected with an α-WSP antibody (red) and 4G2 hybridoma fluid against flavivirus group E antigen for DENV-2 staining (magenta). Slides were imaged as 3-dimensional z-stacks and 2D images generated by MIP using Fiji software. Scale bars = 15 µm. ( D ) LD numbers were quantified 24 h post-DENV-2 infection at MOI 1. LD numbers were analyzed using Fiji software. Data are the mean LD number ± SEM from at least 6 fields of view representing at least 80 cells in total, where each data point represents the mean LD number from a single field of view. Statistical analyses were performed by an unpaired two-tailed student’s t -test, where **** P < 0.0001. ( E ) TEM of Wolbachia -free and w Mel- Aag2 cell lines mock-infected or DENV-2 infected at MOI 1 for 24 h and treated with C75 as previously described. Scale bar = 500 nm. ER, endoplasmic reticulum; W, Wolbachia ; M, mitochondria; Vp, vesicle packets.

    Journal: mBio

    Article Title: Antiviral Wolbachia strains associate with Aedes aegypti endoplasmic reticulum membranes and induce lipid droplet formation to restrict dengue virus replication

    doi: 10.1128/mbio.02495-23

    Figure Lengend Snippet: Disrupting Wolbachia -induced lipid droplets facilitates viral replication in w Mel- Aag2 cell line. Wolbachia -free and w Mel- Aag2 cell lines were mock-infected or DENV-2 infected at MOI 1 for 24 h. Prior to DENV-2 infection cells were pre-treated with C75 for 24 h, and C75 was maintained during the time of infection. ( A–B ) Cell-associated RNA and virus supernatant were collected from each cell line 24 h post-DENV-2-infection for analysis by qRT-PCR ( A ) and TCID 50 ( B ). Data are the median number of viral genome copies ± IQR relative to the RPS17 mosquito housekeeping gene ( A ) or the median TCID 50 /mL ± IQR ( B ). The numbers in parentheses represent the average number of Wolbachia per cell ( Wolbachia 16S rRNA/RPS17 ), determined in parallel wells for each independent experiment prior to DENV-2 inoculation. Data are representative of at least three ( A ) or two independent experiments ( B ) with triplicate biological replicates each. Statistical analyses were performed using Mann-Whitney test, where ** P < 0.001 and **** P < 0.0001. ( C ) Wolbachia -free (top panel) and w Mel- Aag2 cell lines (bottom panel) were stained with BODIPY (green) and DAPI (blue). Wolbachia was detected with an α-WSP antibody (red) and 4G2 hybridoma fluid against flavivirus group E antigen for DENV-2 staining (magenta). Slides were imaged as 3-dimensional z-stacks and 2D images generated by MIP using Fiji software. Scale bars = 15 µm. ( D ) LD numbers were quantified 24 h post-DENV-2 infection at MOI 1. LD numbers were analyzed using Fiji software. Data are the mean LD number ± SEM from at least 6 fields of view representing at least 80 cells in total, where each data point represents the mean LD number from a single field of view. Statistical analyses were performed by an unpaired two-tailed student’s t -test, where **** P < 0.0001. ( E ) TEM of Wolbachia -free and w Mel- Aag2 cell lines mock-infected or DENV-2 infected at MOI 1 for 24 h and treated with C75 as previously described. Scale bar = 500 nm. ER, endoplasmic reticulum; W, Wolbachia ; M, mitochondria; Vp, vesicle packets.

    Article Snippet: Prior to DENV-2 infection cells were pre-treated with 1µM fatty acid synthase (FAS) inhibitor C75 (Abcam) or DMSO diluent only for 24 h. Cells were mock-infected or DENV-2-infected at MOI 1 for 24 h, and C75 was maintained during the time of infection in Aag2 cell culture medium with 10% FBS.

    Techniques: Infection, Virus, Quantitative RT-PCR, MANN-WHITNEY, Staining, Generated, Software, Two Tailed Test

    Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of FAS, SCD1, and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Journal: Stem Cells

    Article Title: Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids

    doi: 10.1002/stem.3452

    Figure Lengend Snippet: Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of FAS, SCD1, and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Article Snippet: FAS inhibitor (C75), SCD1 inhibitor (CAY‐10566), and D6D inhibitor (SC‐26196) were purchased from Cayman.

    Techniques: Derivative Assay, Comparison, Western Blot

    Increased expression of the lipogenic enzymes in human breast cancer tissues. A,C,E, Representative image of IHC analysis for SCD1 (A), FAS (C), and FADS1 (E) expressions in normal and tumor tissues. ANT, tumor‐adjacent normal tissue; T, tumor. B,D,F, Representative image of immunohistochemistry (IHC) analysis for SCD1 (B), FAS (D), and FADS1 (F) expressions between various clinical and tumor grades (G1‐3). *** P < .001 vs vehicle‐treated control cells. Alphabet letters were used to show the significant difference between groups. Each subfigure contains representative image (top) and quantitative results (bottom). The quantitative results were plotted by the values of minimum to maximum

    Journal: Stem Cells

    Article Title: Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids

    doi: 10.1002/stem.3452

    Figure Lengend Snippet: Increased expression of the lipogenic enzymes in human breast cancer tissues. A,C,E, Representative image of IHC analysis for SCD1 (A), FAS (C), and FADS1 (E) expressions in normal and tumor tissues. ANT, tumor‐adjacent normal tissue; T, tumor. B,D,F, Representative image of immunohistochemistry (IHC) analysis for SCD1 (B), FAS (D), and FADS1 (F) expressions between various clinical and tumor grades (G1‐3). *** P < .001 vs vehicle‐treated control cells. Alphabet letters were used to show the significant difference between groups. Each subfigure contains representative image (top) and quantitative results (bottom). The quantitative results were plotted by the values of minimum to maximum

    Article Snippet: FAS inhibitor (C75), SCD1 inhibitor (CAY‐10566), and D6D inhibitor (SC‐26196) were purchased from Cayman.

    Techniques: Expressing, Immunohistochemistry, Control

    n‐3 PUFA inhibit tumor growth of breast cancer stem cells in xenograft mouse model. A, Representative image of tumor‐bearing mice. Prior to implanting 1.5 × 10 7 of MCF‐7‐CSC to nude mice, these mice were orally gavaged by either fish oil (n‐3 PUFA) or corn oil (control) for a month and continued giving oils until the end of the experiment. B, Tumor growth of the nude mice in each group. C, Relative tumor weight by body weight. D, The ratio of n‐6/n‐3 PUFA. E, The ratio of MUFA (C16:1 + C18:1)/SFA (C16:0 + C18:0). F, The ratio of C20:4/C18:2. G,H, Protein levels (G) and mRNA levels (H) of SCD1, FAS, FADS2, and COX2 between control and n‐3 PUFA groups. n = 3 to 4. * P < .05; ** P < .01; *** P < .001 vs control. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Journal: Stem Cells

    Article Title: Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids

    doi: 10.1002/stem.3452

    Figure Lengend Snippet: n‐3 PUFA inhibit tumor growth of breast cancer stem cells in xenograft mouse model. A, Representative image of tumor‐bearing mice. Prior to implanting 1.5 × 10 7 of MCF‐7‐CSC to nude mice, these mice were orally gavaged by either fish oil (n‐3 PUFA) or corn oil (control) for a month and continued giving oils until the end of the experiment. B, Tumor growth of the nude mice in each group. C, Relative tumor weight by body weight. D, The ratio of n‐6/n‐3 PUFA. E, The ratio of MUFA (C16:1 + C18:1)/SFA (C16:0 + C18:0). F, The ratio of C20:4/C18:2. G,H, Protein levels (G) and mRNA levels (H) of SCD1, FAS, FADS2, and COX2 between control and n‐3 PUFA groups. n = 3 to 4. * P < .05; ** P < .01; *** P < .001 vs control. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids

    Article Snippet: FAS inhibitor (C75), SCD1 inhibitor (CAY‐10566), and D6D inhibitor (SC‐26196) were purchased from Cayman.

    Techniques: Control